Division of Gastroenterology, Hepatology and Nutrition, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH 43210, United States
Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH 43210, United States.
World J Gastroenterol. 2017 Dec 28;23(48):8626-8650. doi: 10.3748/wjg.v23.i48.8626.
To critically evaluate previous scientific evidence on Fusobacterium's role in colorectal neoplasia development.
Two independent investigators systematically reviewed all original scientific articles published between January, 2000, and July, 2017, using PubMed, EMBASE, and MEDLINE. A total of 355 articles were screened at the abstract level. Of these, only original scientific human, animal, and in vitro studies investigating and its relationship with colorectal cancer (CRC) were included in the analysis. Abstracts, review articles, studies investigating other colonic diseases, and studies written in other languages than English were excluded from our analysis. Ninety articles were included after removing duplicates, resolving disagreements between the two reviewers, and applying the above criteria.
Studies have consistently identified positive associations between , especially (), and CRC. Stronger associations were seen in CRCs proximal to the splenic flexure and CpG island methylator phenotype (CIMP)-high CRCs. There was evidence of temporality and a biological gradient, with increased DNA detection and quantity along the traditional adenoma-carcinoma sequence and in CIMP-high CRC precursors. Diet may have a differential impact on colonic enrichment; evidence suggests that high fiber diet may reduce the risk of a subset of CRCs that are DNA-positive. Data also suggest shorter CRC and disease-specific survival with increased amount of DNA in CRC tissue. The pathophysiology of enrichment of and other species in colonic tissue is unclear; however, the virulence factors and changes to the local colonic environment with disruption of the protective mucus layer may contribute. The presence of a host lectin (Gal-GalNAc) in the colonic epithelium may also mediate attachment to CRC and precursors through interaction with an protein, fibroblast activation protein 2 (FAP2). The clinical significance of detection or enrichment of in colorectal neoplasia is ambiguous, but data suggest a procarcinogenic effect of , likely due to activation of oncogenic and inflammatory pathways and modulation of the tumor immune environment. This is hypothesized to be mediated by certain strains carrying invasive properties and virulence factors such as FadA and FAP.
Evidence suggests a potential active role of , specifically , in CRC. Future prospective and experimental human studies would fill an important gap in this literature.
批判性地评估以往关于梭杆菌在结直肠肿瘤发展中的作用的科学证据。
两名独立的调查人员使用 PubMed、EMBASE 和 MEDLINE 系统地审查了 2000 年 1 月至 2017 年 7 月期间发表的所有原始科学文章。在摘要水平上筛选了 355 篇文章。其中,只有原始的科学人类、动物和体外研究调查了其与结直肠癌(CRC)的关系,并将其纳入分析。摘要、综述文章、研究其他结肠疾病的文章以及用英语以外的语言撰写的文章均被排除在我们的分析之外。在去除重复项、解决两位评审员之间的分歧并应用上述标准后,有 90 篇文章被纳入分析。
研究一致发现,梭杆菌,特别是()与 CRC 之间存在正相关关系。在脾曲附近和 CpG 岛甲基化表型(CIMP)高 CRC 中观察到更强的相关性。存在时间性和生物学梯度,随着传统腺瘤-癌序列和 CIMP 高 CRC 前体中检测到的和数量的增加而增加。饮食可能对结肠的富集产生不同的影响;有证据表明,高纤维饮食可能降低一组 DNA 阳性的 CRC 的风险。数据还表明,CRC 组织中 DNA 量增加与较短的 CRC 和疾病特异性生存时间相关。在结肠组织中富集梭杆菌和其他梭杆菌物种的病理生理学尚不清楚;然而,破坏保护性粘液层可能会导致细菌的毒力因子和局部结肠环境发生变化。结肠上皮中宿主凝集素(Gal-GalNAc)的存在也可能通过与成纤维细胞激活蛋白 2(FAP2)的相互作用介导与 CRC 和前体的结合。在结直肠肿瘤中检测或富集的临床意义尚不清楚,但数据表明,可能由于激活致癌和炎症途径以及调节肿瘤免疫环境,梭杆菌具有致癌作用。这被假设是由携带侵袭性特性和毒力因子(如 FadA 和 FAP)的某些梭杆菌菌株介导的。
有证据表明,梭杆菌,特别是梭杆菌,在 CRC 中可能具有潜在的积极作用。未来的前瞻性和实验性人体研究将填补该文献中的重要空白。